As shown in Figure 2, some indole derivatives, which are reported as anti-cancer agents targeting MDM2 and MDMX (1b, RO-2443) [36,39], have been modified to improve the activities and explore new mechanisms. The gene discussed is MDM2; the disease is cancer.